Updated Jul 16, 2026
Roush John A has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $4.00M.

John A. Roush is a director at LeMaitre Vascular Inc, a company that specializes in medical devices for treating peripheral vascular disease. He has been involved in multiple SEC filings related to his role, but there is limited publicly available information about his career or achievements.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-06 | AEIS | ADVANCED ENERGY INDUSTRIES INC | M — Option exercise | 2.3K | — | |
| 2026-03-06 | AEIS | ADVANCED ENERGY INDUSTRIES INC | S — Open-market sale [10b5-1] | 300 | $326.75 | $98K |
| 2026-03-06 | AEIS | ADVANCED ENERGY INDUSTRIES INC | S — Open-market sale [10b5-1] | 2.7K | $325.26 | $880K |
| 2026-03-06 | AEIS | ADVANCED ENERGY INDUSTRIES INC | S — Open-market sale [10b5-1] | 3.3K | $324.29 | $1.07M |
| 2026-03-06 | AEIS | ADVANCED ENERGY INDUSTRIES INC | S — Open-market sale [10b5-1] | 500 | $323.79 | $162K |
| 2026-03-06 | AEIS | ADVANCED ENERGY INDUSTRIES INC | S — Open-market sale [10b5-1] | 1.7K | $322.32 | $557K |
| 2026-03-06 | AEIS | ADVANCED ENERGY INDUSTRIES INC | S — Open-market sale [10b5-1] | 500 | $320.76 | $160K |
| 2026-03-06 | AEIS | ADVANCED ENERGY INDUSTRIES INC | S — Open-market sale [10b5-1] | 1.2K | $319.78 | $384K |
| 2026-03-03 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 1 | $0.00 | |
| 2026-03-03 | LMAT | LEMAITRE VASCULAR INC | A — Grant or award | 476 | $0.00 | |
| 2025-12-11 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 3 | $0.00 | |
| 2025-12-11 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 2 | $0.00 | |
| 2025-12-09 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 1 | $0.00 | |
| 2025-08-08 | LMAT | LEMAITRE VASCULAR INC | S — Open-market sale | 1.6K | $91.82 | $145K |
| 2025-08-08 | LMAT | LEMAITRE VASCULAR INC | S — Open-market sale | 5.0K | $92.78 | $463K |
| 2025-08-08 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 6.6K | $37.29 | $245K |
| 2025-08-08 | LMAT | LEMAITRE VASCULAR INC | S — Open-market sale | 939 | $93.49 | $88K |
| 2025-08-08 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 939 | $37.29 | $35K |
| 2024-12-13 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 3 | $0.00 | |
| 2024-12-13 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 3 | $0.00 |
John A. Roush is a director at LeMaitre Vascular Inc, a company that specializes in medical devices for treating peripheral vascular disease. He has been involved in multiple SEC filings related to his role, but there is limited publicly available information about his career or achievements.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 10 open-market sales ($4.00M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Roush John A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.